Passage Bio reduces staff by 26% in latest round of job cuts


The job cuts at Philadelphia gene therapy developer Passage Bio include the company's CFO and chief technical officer.

Previous Office leasing activity in Cleveland market remains unsettled in Q2
Next Alamo City Ticker Visiting Teams: Houston developer nearly doubling apartments at Brooks